GR-DD1

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameGR-DD1
Drug Alias Namecytotoxin (ERYtech)GR-DD1
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionMetastasis inhibitors
TargetsUpdating
Therapy Area/IndicationsLiver Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPhaxiam Therapeutics SA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPhaxiam Therapeutics SA
Active IndicationsN/A
Inactive IndicationsLiver Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A